SCHEMBL6892764

SCHEMBL6892764

CCc1cc(O)c2c3c(C(=O)OC)cccc3n(Cc3ccccc3F)c2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
ALDH1A1 P00352 4/20 0.42
KDM4E B2RXH2 1/20 0.42
KMT2A Q03164 3/20 0.40
MEN1 O00255 2/20 0.40
TP53 P04637 2/20 0.39
PTGER3 P43115 1/20 0.39
RXFP1 Q9HBX9 1/20 0.39
POLB P06746 1/20 0.39
THRB P10828 1/20 0.39
MAPK1 P28482 2/20 0.38
MAPT P10636 2/20 0.38
GAA P10253 1/20 0.38
ALOX15 P16050 1/20 0.38
NPC1 O15118 1/20 0.38
TSHR P16473 1/20 0.38
HSP90AA1 P07900 1/20 0.38
HSP90B1 P14625 1/20 0.38
P2RX7 Q99572 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6895065 0.91 LMNA (0.40) LMNAL3MBTL1ALDH1A1KDM4EKMT2A
SCHEMBL6773681 0.90 ALDH1A1 (0.42) LMNAL3MBTL1ALDH1A1KDM4EKMT2A
SCHEMBL6898392 0.89 L3MBTL1 (0.44) LMNAL3MBTL1ALDH1A1KDM4EKMT2A
SCHEMBL6894723 0.89 MAPT (0.45) LMNAL3MBTL1ALDH1A1KDM4EKMT2A
SCHEMBL6691803 0.88 LMNA (0.47) LMNAL3MBTL1ALDH1A1KDM4EKMT2A
SCHEMBL6890571 0.88 MAPT (0.45) LMNAL3MBTL1ALDH1A1KDM4EKMT2A
SCHEMBL6894204 0.88 L3MBTL1 (0.44) LMNAL3MBTL1ALDH1A1KDM4EKMT2A
SCHEMBL6892130 0.88 HSP90AA1 (0.38) LMNAALDH1A1KDM4EKMT2AMEN1
SCHEMBL6894814 0.87 MAPT (0.44) LMNAL3MBTL1ALDH1A1KDM4EKMT2A
SCHEMBL6895550 0.87 KIF11 (0.42) ALDH1A1KDM4EKMT2AMEN1HSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6713645-B1 INHIBITING SPLA2 MEDIATED RELEASE OF FATTY ACIDS FOR TREATMENT OF CONDITIONS SUCH AS SEPTIC SHOCK ELI LILLY AND COMPANY 2004-03-30 US disclosed
US-6177440-B1 THERAPY FOR SEPSIS SHOCK; PHOSPHOLIPASE INHBITOR ELI LILLY AND COMPANY 2001-01-23 US disclosed
EP-0952149-A2 Substituted carbazoles, process for their preparation and their use as sPLA2 inhibitiors ELI LILLY AND COMPANY (US) 1999-10-27 EP disclosed